Warfarin Sodium, amorphous

Warfarin Sodium, amorphous; API; EP, USP, JP, ANVISA; [129-06-6]

Description

Warfarin Sodium, amorphous is a synthetically synthesized Active Pharmaceutical Ingredient, produced under cGMP, compliant with EP monograph. Its CAS-N° reads [129-06-6]. It is used to treat or prevent blood clots in veins or arteries, which can reduce the risk of stroke, heart attack, or other serious conditions. Detailed specification, Certificate of Analysis and samples are available on request. Warfarin sodium is a 4-hydroxycumarin, these are known as vitamin K antagonists. Vitamin K antagonists are anticoagulants that encroach on the blood clotting cascade. Since the substance can have significant fluctuations in its effectiveness, depending on the genotype, the blood clotting levels for dose tuning should be tested regularly.

Pharmaceutical products

warfarin
anticoagulant
heart attack

Product features

CAS	129-06-6
Product Information	API
Route of Synthesis	Synthetic
Patent Expiry	EU, US - expired
Indication	Anticoagulant, Tromboembosism
Dosage	Oral and iv formulation